Mark Roh

Statistics

Publications

Citations

H-Index

Active since

1994

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Mark Roh is an author at The University of Texas MD Anderson Cancer Center specializing in antibody characterization, monoclonal antibodies in oncology, and pharmacokinetics of monoclonal antibodies.

Publications per year

1994–1994

Publications

Comparative tumor localization of whole immunoglobulin g anticarcinoembryonic antigen monoclonal antibodies immu-4 and immu-4 f(ab′)2 in colorectal cancer patients

James L. Murray, Michael G. Rosenblum, Hua-Zhong Zhang et al. · Cancer · 1994 · 18 citations · Full text

Pharmacy, Nuclear Medicine, Oncology +16

Clinical pharmacology and tissue disposition studies of131I-labeled anticolorectal carcinoma human monoclonal antibody LiCO 16.88

M. G. Rosenblum, Bernard Levin, Mark Roh et al. · Cancer Immunology Immunotherapy · 1994 · 10 citations · Full text

Medicine, Oncology, Pharmacology +11

1–2 of 2